NCT00698893View on ClinicalTrials.gov

Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

May 1, 1992

Primary Completion Date

July 1, 1992

Study Completion Date

July 1, 1992

Conditions

Herpes Simplex

Interventions

BIOLOGICAL

Herpes simplex candidate (gD) vaccine GSK208141

Intramuscular injection, 2 doses, 2 different formulations (with and without MPL)

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00698893 - Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults | Biotech Hunter | Biotech Hunter